Home β€Ί Stock analysis β€Ί PROK

Prokidney (PROK) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

PROK slides 8.6% to $1.33, a 1-month low, 5 down days in a row. Closed at $1.33, -8.59% vs the prior close of $1.46. Day range $1.30–$1.47, opened at $1.43.

Last close$1.33-8.59%
Day range1.30–1.47
Open1.43
Volume1.65M
52-week range1.30–3.48
Avg volume (20d)1.32M

PROK daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” PROK slides 8.6% to $1.33, a 1-month low, 5 down days in a row
Oct 15, 2026 β€” PROK dips 1.0% to $1.46, a 1-month low, 4 down days in a row
Oct 14, 2026 β€” PROK slides 6.4% to $1.47, a 1-month low, 3 down days in a row
Oct 13, 2026 β€” PROK slides 6.0% to $1.57
Oct 12, 2026 β€” PROK slides 4.0% to $1.67
Oct 9, 2026 β€” PROK jumps 4.8% to $1.74
Oct 8, 2026 β€” PROK jumps 5.7% to $1.66
Oct 7, 2026 β€” PROK dips 1.9% to $1.57, a 1-month low
Oct 6, 2026 β€” PROK rises 1.3% to $1.60
Oct 5, 2026 β€” PROK slides 8.1% to $1.58, a 1-month low
Oct 2, 2026 β€” PROK rises 0.6% to $1.72, 5 up days in a row

PROK latest news & SEC filings

Every SEC filing by or about PROK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Aug 20, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001193125-26-359349

Aug 18, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001628280-26-057713

Aug 18, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001628280-26-057710

Aug 12, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000895421-26-000226

Aug 10, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001193125-26-342397

Aug 10, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001193125-26-342373

Aug 6, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001193125-26-336856

Jul 6, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001193125-26-296160

Things to know before you trade PROK

PROK market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20261.431.471.301.331.65M
Oct 15, 20261.441.491.421.461.11M
Oct 14, 20261.541.571.411.472.13M
Oct 13, 20261.651.681.531.571.59M
Oct 12, 20261.711.741.661.67607.80K
Oct 9, 20261.651.751.631.741.39M
Oct 8, 20261.551.671.531.661.13M
Oct 7, 20261.561.601.551.57831.60K
Oct 6, 20261.581.611.551.60770.60K
Oct 5, 20261.691.741.581.58981.80K
Oct 2, 20261.721.751.661.721.09M
Oct 1, 20261.661.761.631.711.50M
Sep 30, 20261.651.671.601.661.20M
Sep 29, 20261.611.681.611.631.00M
Sep 28, 20261.581.641.541.611.81M
Sep 25, 20261.671.691.571.602.17M
Sep 24, 20261.651.691.601.681.72M
Sep 23, 20261.811.841.651.651.44M
Sep 22, 20261.781.861.771.83588.50K
Sep 21, 20261.901.911.721.771.77M

About Prokidney

Prokidney (PROK) is listed on the Nasdaq and classified by the SEC under β€œBiological Products, (No Diagnostic Substances)”. Its business address is in WINSTON-SALEM, NC. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1850270.

PROK board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Bruce CulletonChief Executive OfficerMar 3, 2026
William F DoyleDirectorMay 29, 2026
Jennifer A. FoxDirectorMay 29, 2026
Santos Jose Ignacio JimenezDirectorMay 29, 2026
Pablo G. LegorretaDirectorMay 29, 2026
Alan LotvinDirectorMay 29, 2026
Brian Jg PereiraDirectorAug 20, 2026
Uma SinhaDirectorMay 29, 2026

Executive officers

NameTitleLatest filing
James CoulstonChief Financial OfficerMar 3, 2026
Bruce CulletonChief Executive OfficerMar 3, 2026
Todd C GirolamoChief Legal OfficerJun 15, 2026
Kenneth Thomas LockeChief Technical OfficerJul 6, 2026
Darin J. WeberChief Regulatory OfficerMar 3, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Aug 20, 2026Brian Jg PereiraSale27,052$1.42
Aug 20, 2026Brian Jg PereiraSale222,948$1.42
Aug 20, 2026Brian Jg PereiraSale27,052$1.42
Aug 20, 2026Brian Jg PereiraSale222,948$1.42
Aug 20, 2026Brian Jg PereiraSale27,052$1.42
Aug 20, 2026Brian Jg PereiraSale222,948$1.42
Aug 20, 2026Brian Jg PereiraSale27,052$1.42
Aug 20, 2026Brian Jg PereiraSale222,948$1.42
Aug 19, 2026Brian Jg PereiraSale27,051$1.44
Aug 19, 2026Brian Jg PereiraSale222,949$1.44
Aug 19, 2026Brian Jg PereiraSale27,051$1.44
Aug 19, 2026Brian Jg PereiraSale222,949$1.44
Aug 19, 2026Brian Jg PereiraSale27,051$1.44
Aug 19, 2026Brian Jg PereiraSale222,949$1.44
Aug 19, 2026Brian Jg PereiraSale27,051$1.44

PROK financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025β€”$-68.99Mβ€”$-120.12M
Dec 31, 2024β€”$-61.19Mβ€”$-126.35M
Dec 31, 2023β€”$-35.47Mβ€”$-90.07M
Dec 31, 2021β€”$-55.15Mβ€”$-50.30M

Latest balance sheet: total assets $249.02M, total liabilities $26.18M, cash $74.87M (as of Jun 30, 2026).

PROK earnings / results-day log

DateFilingClose that day
Aug 10, 20268-K Item 2.02 (results)$1.69
May 15, 20268-K Item 2.02 (results)$1.66
Mar 18, 20268-K Item 2.02 (results)$2.08
Nov 10, 20258-K Item 2.02 (results)$2.70
Aug 12, 20258-K Item 2.02 (results)$2.24
May 12, 20258-K Item 2.02 (results)$0.75
Mar 17, 20258-K Item 2.02 (results)$1.04
Nov 12, 20248-K Item 2.02 (results)$2.05
Aug 9, 20248-K Item 2.02 (results)β€”
May 10, 20248-K Item 2.02 (results)β€”
Mar 22, 20248-K Item 2.02 (results)β€”
Nov 14, 20238-K Item 2.02 (results)β€”

Related stocks Β· Biological Products, (No Diagnostic Substances)

Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on PROK

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.